Kamada (KMDA) Enters Recombinant Human Alpha 1 Antitrypsin Development Agreement
Go back to Kamada (KMDA) Enters Recombinant Human Alpha 1 Antitrypsin Development AgreementKAMADA LTD (NASDAQ: KMDA) | Delayed: 5.60 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $5.60 | 52 Week High | $6.29 | |||
Open | $5.60 | 52 Week Low | $3.26 | |||
Day High | $5.60 | P/E | N/A | |||
Day Low | $5.60 | EPS | $0.00 | |||
Volume | 15 |